Enhanced Protection Efficacy of Reduced Glutathione Loaded Lactosaminated Carboxymethyl Chitosan Nanoparticles on Rats Non-Alcoholic Fatty Liver Disease Model

Guangyi Zhu,Chunbao Zhao,Wei Han,Yuanyuan Chen,Chuang Xu,Cheng Xia,Xinhuan Xiao,Gang Wang
DOI: https://doi.org/10.1166/jbt.2018.1742
2018-01-01
Journal of Biomaterials and Tissue Engineering
Abstract:Nonalcoholic fatty liver disease (NAFLD) is recognized as one of the most common chronic liver diseases in general population. The protection role of reduced glutathione (rGSH) in nanoparticles drug delivery system on rat NAFLD model was investigated. NAFLD rat model was established by high-fat-diet feeding (HFD), and rGSH loaded lactose modified carboxymethyl chitosan (LAC-CMC) nanoparticles (NP) was administrated by intravenous injection. Effects of rGSH on rat hepatotoxic indices, lipid profile and inflammation cytokines of different treated groups were assessed. The treatments with rGSH-LACMC-NPs significantly decreased liver index, aspartate aminotransferase (ALT) and alanine aminotransferase (AST) levels, and reduced levels of cholesterol and triglyceride and non-high density lipoprotein (non-HDL) as regard to HFD group Moreover, administration of rGSH-LACMC-NPs clearly inhibited hepatic protein expression levels of peroxisome proliferator-activated receptor (PPAR)-gamma, transforming growth factor (TGF)-beta 1, and tumor necrosis factor (TNF)-alpha. Reduced GSH exerted a significant protection effects on the NAFLD model, and LAC-CMC nanomaterials enhanced the bioavailability of rGSH in liver, The rGSH-LACMC-NP may be used as a potential treatment for NAFLD.
What problem does this paper attempt to address?